Head-to-head · Cost-Efficiency Index
Next Vial vs Chia
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Next Vial
Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee.
Visit Next VialChia
Shoppers who want month-to-month GLP-1 care with a money-back guarantee, and who will compare the committed-plan discount against its early-cancellation math.
Visit ChiaThe verdict
Next Vial and Chia tie on the Cost-Efficiency Index at 63/100, so neither wins outright on the numbers, so choose on fit. Next Vial: Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee. Chia: Shoppers who want month-to-month GLP-1 care with a money-back guarantee, and who will compare the committed-plan discount against its early-cancellation math.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Next Vial.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Next Vial | Chia |
|---|---|---|
| Cost-Efficiency Index | 63/100 | 63/100 |
| Semaglutide / mo | $249/moAll doses, compounded | $349/moMonth to month, compounded; $249/mo on a committed multi-month plan |
| Tirzepatide / mo | $249/moAll doses, compounded | $399/moMonth to month, compounded; from $249/mo on a committed multi-month plan |
| Semaglutide / yr (modeled) | $2,988 | $4,188 |
| Tirzepatide / yr (modeled) | $2,988 | $4,788 |
| Coverage | 49 states | Not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #244 | #250 |
Next Vial
63/100Where the value is
- Names its compounding pharmacy partner explicitly (Manifest Pharmacy, Greer, SC)
- Genuine LegitScript verification link in the footer
- Explicit 44-state coverage list published in the FAQ
The tradeoffs
- Starting price is blended/generic ($249.97/mo) and not broken out by drug or dose tier anywhere public
- No individual medical director named
Chia
63/100Where the value is
- Month-to-month plans carry a 30-day money-back guarantee for first-time weight-loss customers
- Both the committed-plan figure and the month-to-month figure appear on the product page before the quiz
- Offers a daily tirzepatide tablet as well as weekly injections
The tradeoffs
- The "Starting from $249.00/mo" headline is a committed 3-, 4- or 6-month plan price; month to month is $349 for semaglutide and $399 for tirzepatide
- Cancel a committed plan early and your refund is recalculated at the full monthly rate for the months you used, which can leave nothing back
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.